1 Study Coverage 1.1 Live Vaccines Product Introduction 1.2 Market Segments 1.3 Key Live Vaccines Manufacturers Covered: Ranking by Revenue 1.4 Market by Type 1.4.1 Global Live Vaccines Market Size Growth Rate by Type 1.4.2 Monovalent Live Vaccines 1.4.3 Multivalent Live Vaccines 1.5 Market by Application 1.5.1 Global Live Vaccines Market Size Growth Rate by Application 1.5.2 Adults 1.5.3 Children 1.6 Coronavirus Disease 2019 (Covid-19): Live Vaccines Industry Impact 1.6.1 How the Covid-19 is Affecting the Live Vaccines Industry 1.6.1.1 Live Vaccines Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Live Vaccines Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Live Vaccines Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Executive Summary 2.1 Global Live Vaccines Market Size Estimates and Forecasts 2.1.1 Global Live Vaccines Revenue 2015-2026 2.1.2 Global Live Vaccines Sales 2015-2026 2.2 Live Vaccines Market Size by Region: 2020 Versus 2026 2.2.1 Global Live Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020 2.2.2 Global Live Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020 3 Global Live Vaccines Competitor Landscape by Players 3.1 Live Vaccines Sales by Manufacturers 3.1.1 Live Vaccines Sales by Manufacturers (2015-2020) 3.1.2 Live Vaccines Sales Market Share by Manufacturers (2015-2020) 3.2 Live Vaccines Revenue by Manufacturers 3.2.1 Live Vaccines Revenue by Manufacturers (2015-2020) 3.2.2 Live Vaccines Revenue Share by Manufacturers (2015-2020) 3.2.3 Global Live Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020) 3.2.4 Global Top 10 and Top 5 Companies by Live Vaccines Revenue in 2019 3.2.5 Global Live Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Live Vaccines Price by Manufacturers 3.4 Live Vaccines Manufacturing Base Distribution, Product Types 3.4.1 Live Vaccines Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Live Vaccines Product Type 3.4.3 Date of International Manufacturers Enter into Live Vaccines Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Live Vaccines Market Size by Type (2015-2020) 4.1.1 Global Live Vaccines Sales by Type (2015-2020) 4.1.2 Global Live Vaccines Revenue by Type (2015-2020) 4.1.3 Live Vaccines Average Selling Price (ASP) by Type (2015-2026) 4.2 Global Live Vaccines Market Size Forecast by Type (2021-2026) 4.2.1 Global Live Vaccines Sales Forecast by Type (2021-2026) 4.2.2 Global Live Vaccines Revenue Forecast by Type (2021-2026) 4.2.3 Live Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026) 4.3 Global Live Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Breakdown Data by Application (2015-2026) 5.1 Global Live Vaccines Market Size by Application (2015-2020) 5.1.1 Global Live Vaccines Sales by Application (2015-2020) 5.1.2 Global Live Vaccines Revenue by Application (2015-2020) 5.1.3 Live Vaccines Price by Application (2015-2020) 5.2 Live Vaccines Market Size Forecast by Application (2021-2026) 5.2.1 Global Live Vaccines Sales Forecast by Application (2021-2026) 5.2.2 Global Live Vaccines Revenue Forecast by Application (2021-2026) 5.2.3 Global Live Vaccines Price Forecast by Application (2021-2026) 6 North America 6.1 North America Live Vaccines by Country 6.1.1 North America Live Vaccines Sales by Country 6.1.2 North America Live Vaccines Revenue by Country 6.1.3 U.S. 6.1.4 Canada 6.2 North America Live Vaccines Market Facts & Figures by Type 6.3 North America Live Vaccines Market Facts & Figures by Application 7 Europe 7.1 Europe Live Vaccines by Country 7.1.1 Europe Live Vaccines Sales by Country 7.1.2 Europe Live Vaccines Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 U.K. 7.1.6 Italy 7.1.7 Russia 7.2 Europe Live Vaccines Market Facts & Figures by Type 7.3 Europe Live Vaccines Market Facts & Figures by Application 8 Asia Pacific 8.1 Asia Pacific Live Vaccines by Region 8.1.1 Asia Pacific Live Vaccines Sales by Region 8.1.2 Asia Pacific Live Vaccines Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Taiwan 8.1.9 Indonesia 8.1.10 Thailand 8.1.11 Malaysia 8.1.12 Philippines 8.1.13 Vietnam 8.2 Asia Pacific Live Vaccines Market Facts & Figures by Type 8.3 Asia Pacific Live Vaccines Market Facts & Figures by Application 9 Latin America 9.1 Latin America Live Vaccines by Country 9.1.1 Latin America Live Vaccines Sales by Country 9.1.2 Latin America Live Vaccines Revenue by Country 9.1.3 Mexico 9.1.4 Brazil 9.1.5 Argentina 9.2 Central & South America Live Vaccines Market Facts & Figures by Type 9.3 Central & South America Live Vaccines Market Facts & Figures by Application 10 Middle East and Africa 10.1 Middle East and Africa Live Vaccines by Country 10.1.1 Middle East and Africa Live Vaccines Sales by Country 10.1.2 Middle East and Africa Live Vaccines Revenue by Country 10.1.3 Turkey 10.1.4 Saudi Arabia 10.1.5 U.A.E 10.2 Middle East and Africa Live Vaccines Market Facts & Figures by Type 10.3 Middle East and Africa Live Vaccines Market Facts & Figures by Application 11 Company Profiles 11.1 Merck 11.1.1 Merck Corporation Information 11.1.2 Merck Description, Business Overview and Total Revenue 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Merck Live Vaccines Products Offered 11.1.5 Merck Recent Development 11.2 GlaxoSmithKline 11.2.1 GlaxoSmithKline Corporation Information 11.2.2 GlaxoSmithKline Description, Business Overview and Total Revenue 11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020) 11.2.4 GlaxoSmithKline Live Vaccines Products Offered 11.2.5 GlaxoSmithKline Recent Development 11.3 Pfizer 11.3.1 Pfizer Corporation Information 11.3.2 Pfizer Description, Business Overview and Total Revenue 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020) 11.3.4 Pfizer Live Vaccines Products Offered 11.3.5 Pfizer Recent Development 11.4 Novartis 11.4.1 Novartis Corporation Information 11.4.2 Novartis Description, Business Overview and Total Revenue 11.4.3 Novartis Sales, Revenue and Gross Margin (2015-2020) 11.4.4 Novartis Live Vaccines Products Offered 11.4.5 Novartis Recent Development 11.5 Astellas Pharma 11.5.1 Astellas Pharma Corporation Information 11.5.2 Astellas Pharma Description, Business Overview and Total Revenue 11.5.3 Astellas Pharma Sales, Revenue and Gross Margin (2015-2020) 11.5.4 Astellas Pharma Live Vaccines Products Offered 11.5.5 Astellas Pharma Recent Development 11.6 Emergent BioSolutions 11.6.1 Emergent BioSolutions Corporation Information 11.6.2 Emergent BioSolutions Description, Business Overview and Total Revenue 11.6.3 Emergent BioSolutions Sales, Revenue and Gross Margin (2015-2020) 11.6.4 Emergent BioSolutions Live Vaccines Products Offered 11.6.5 Emergent BioSolutions Recent Development 11.7 AstraZeneca 11.7.1 AstraZeneca Corporation Information 11.7.2 AstraZeneca Description, Business Overview and Total Revenue 11.7.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020) 11.7.4 AstraZeneca Live Vaccines Products Offered 11.7.5 AstraZeneca Recent Development 11.1 Merck 11.1.1 Merck Corporation Information 11.1.2 Merck Description, Business Overview and Total Revenue 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020) 11.1.4 Merck Live Vaccines Products Offered 11.1.5 Merck Recent Development 12 Future Forecast by Regions (Countries) (2021-2026) 12.1 Live Vaccines Market Estimates and Projections by Region 12.1.1 Global Live Vaccines Sales Forecast by Regions 2021-2026 12.1.2 Global Live Vaccines Revenue Forecast by Regions 2021-2026 12.2 North America Live Vaccines Market Size Forecast (2021-2026) 12.2.1 North America: Live Vaccines Sales Forecast (2021-2026) 12.2.2 North America: Live Vaccines Revenue Forecast (2021-2026) 12.2.3 North America: Live Vaccines Market Size Forecast by Country (2021-2026) 12.3 Europe Live Vaccines Market Size Forecast (2021-2026) 12.3.1 Europe: Live Vaccines Sales Forecast (2021-2026) 12.3.2 Europe: Live Vaccines Revenue Forecast (2021-2026) 12.3.3 Europe: Live Vaccines Market Size Forecast by Country (2021-2026) 12.4 Asia Pacific Live Vaccines Market Size Forecast (2021-2026) 12.4.1 Asia Pacific: Live Vaccines Sales Forecast (2021-2026) 12.4.2 Asia Pacific: Live Vaccines Revenue Forecast (2021-2026) 12.4.3 Asia Pacific: Live Vaccines Market Size Forecast by Region (2021-2026) 12.5 Latin America Live Vaccines Market Size Forecast (2021-2026) 12.5.1 Latin America: Live Vaccines Sales Forecast (2021-2026) 12.5.2 Latin America: Live Vaccines Revenue Forecast (2021-2026) 12.5.3 Latin America: Live Vaccines Market Size Forecast by Country (2021-2026) 12.6 Middle East and Africa Live Vaccines Market Size Forecast (2021-2026) 12.6.1 Middle East and Africa: Live Vaccines Sales Forecast (2021-2026) 12.6.2 Middle East and Africa: Live Vaccines Revenue Forecast (2021-2026) 12.6.3 Middle East and Africa: Live Vaccines Market Size Forecast by Country (2021-2026) 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Porter’s Five Forces Analysis 13.5 Primary Interviews with Key Live Vaccines Players (Opinion Leaders) 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Live Vaccines Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details

List of Tables Table 1. Live Vaccines Market Segments Table 2. Ranking of Global Top Live Vaccines Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Live Vaccines Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million) Table 4. Major Manufacturers of Monovalent Live Vaccines Table 5. Major Manufacturers of Multivalent Live Vaccines Table 6. COVID-19 Impact Global Market: (Four Live Vaccines Market Size Forecast Scenarios) Table 7. Opportunities and Trends for Live Vaccines Players in the COVID-19 Landscape Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 9. Key Regions/Countries Measures against Covid-19 Impact Table 10. Proposal for Live Vaccines Players to Combat Covid-19 Impact Table 11. Global Live Vaccines Market Size Growth Rate by Application 2020-2026 (K Doses) Table 12. Global Live Vaccines Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026 Table 13. Global Live Vaccines Sales by Regions 2015-2020 (K Doses) Table 14. Global Live Vaccines Sales Market Share by Regions (2015-2020) Table 15. Global Live Vaccines Revenue by Regions 2015-2020 (US$ Million) Table 16. Global Live Vaccines Sales by Manufacturers (2015-2020) (K Doses) Table 17. Global Live Vaccines Sales Share by Manufacturers (2015-2020) Table 18. Global Live Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 19. Global Live Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Live Vaccines as of 2019) Table 20. Live Vaccines Revenue by Manufacturers (2015-2020) (US$ Million) Table 21. Live Vaccines Revenue Share by Manufacturers (2015-2020) Table 22. Key Manufacturers Live Vaccines Price (2015-2020) (USD/Dose) Table 23. Live Vaccines Manufacturers Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Live Vaccines Product Type Table 25. Date of International Manufacturers Enter into Live Vaccines Market Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans Table 27. Global Live Vaccines Sales by Type (2015-2020) (K Doses) Table 28. Global Live Vaccines Sales Share by Type (2015-2020) Table 29. Global Live Vaccines Revenue by Type (2015-2020) (US$ Million) Table 30. Global Live Vaccines Revenue Share by Type (2015-2020) Table 31. Live Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Dose) Table 32. Global Live Vaccines Sales by Application (2015-2020) (K Doses) Table 33. Global Live Vaccines Sales Share by Application (2015-2020) Table 34. North America Live Vaccines Sales by Country (2015-2020) (K Doses) Table 35. North America Live Vaccines Sales Market Share by Country (2015-2020) Table 36. North America Live Vaccines Revenue by Country (2015-2020) (US$ Million) Table 37. North America Live Vaccines Revenue Market Share by Country (2015-2020) Table 38. North America Live Vaccines Sales by Type (2015-2020) (K Doses) Table 39. North America Live Vaccines Sales Market Share by Type (2015-2020) Table 40. North America Live Vaccines Sales by Application (2015-2020) (K Doses) Table 41. North America Live Vaccines Sales Market Share by Application (2015-2020) Table 42. Europe Live Vaccines Sales by Country (2015-2020) (K Doses) Table 43. Europe Live Vaccines Sales Market Share by Country (2015-2020) Table 44. Europe Live Vaccines Revenue by Country (2015-2020) (US$ Million) Table 45. Europe Live Vaccines Revenue Market Share by Country (2015-2020) Table 46. Europe Live Vaccines Sales by Type (2015-2020) (K Doses) Table 47. Europe Live Vaccines Sales Market Share by Type (2015-2020) Table 48. Europe Live Vaccines Sales by Application (2015-2020) (K Doses) Table 49. Europe Live Vaccines Sales Market Share by Application (2015-2020) Table 50. Asia Pacific Live Vaccines Sales by Region (2015-2020) (K Doses) Table 51. Asia Pacific Live Vaccines Sales Market Share by Region (2015-2020) Table 52. Asia Pacific Live Vaccines Revenue by Region (2015-2020) (US$ Million) Table 53. Asia Pacific Live Vaccines Revenue Market Share by Region (2015-2020) Table 54. Asia Pacific Live Vaccines Sales by Type (2015-2020) (K Doses) Table 55. Asia Pacific Live Vaccines Sales Market Share by Type (2015-2020) Table 56. Asia Pacific Live Vaccines Sales by Application (2015-2020) (K Doses) Table 57. Asia Pacific Live Vaccines Sales Market Share by Application (2015-2020) Table 58. Latin America Live Vaccines Sales by Country (2015-2020) (K Doses) Table 59. Latin America Live Vaccines Sales Market Share by Country (2015-2020) Table 60. Latin Americaa Live Vaccines Revenue by Country (2015-2020) (US$ Million) Table 61. Latin America Live Vaccines Revenue Market Share by Country (2015-2020) Table 62. Latin America Live Vaccines Sales by Type (2015-2020) (K Doses) Table 63. Latin America Live Vaccines Sales Market Share by Type (2015-2020) Table 64. Latin America Live Vaccines Sales by Application (2015-2020) (K Doses) Table 65. Latin America Live Vaccines Sales Market Share by Application (2015-2020) Table 66. Middle East and Africa Live Vaccines Sales by Country (2015-2020) (K Doses) Table 67. Middle East and Africa Live Vaccines Sales Market Share by Country (2015-2020) Table 68. Middle East and Africa Live Vaccines Revenue by Country (2015-2020) (US$ Million) Table 69. Middle East and Africa Live Vaccines Revenue Market Share by Country (2015-2020) Table 70. Middle East and Africa Live Vaccines Sales by Type (2015-2020) (K Doses) Table 71. Middle East and Africa Live Vaccines Sales Market Share by Type (2015-2020) Table 72. Middle East and Africa Live Vaccines Sales by Application (2015-2020) (K Doses) Table 73. Middle East and Africa Live Vaccines Sales Market Share by Application (2015-2020) Table 74. Merck Corporation Information Table 75. Merck Description and Major Businesses Table 76. Merck Live Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 77. Merck Product Table 78. Merck Recent Development Table 79. GlaxoSmithKline Corporation Information Table 80. GlaxoSmithKline Description and Major Businesses Table 81. GlaxoSmithKline Live Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 82. GlaxoSmithKline Product Table 83. GlaxoSmithKline Recent Development Table 84. Pfizer Corporation Information Table 85. Pfizer Description and Major Businesses Table 86. Pfizer Live Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 87. Pfizer Product Table 88. Pfizer Recent Development Table 89. Novartis Corporation Information Table 90. Novartis Description and Major Businesses Table 91. Novartis Live Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 92. Novartis Product Table 93. Novartis Recent Development Table 94. Astellas Pharma Corporation Information Table 95. Astellas Pharma Description and Major Businesses Table 96. Astellas Pharma Live Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 97. Astellas Pharma Product Table 98. Astellas Pharma Recent Development Table 99. Emergent BioSolutions Corporation Information Table 100. Emergent BioSolutions Description and Major Businesses Table 101. Emergent BioSolutions Live Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 102. Emergent BioSolutions Product Table 103. Emergent BioSolutions Recent Development Table 104. AstraZeneca Corporation Information Table 105. AstraZeneca Description and Major Businesses Table 106. AstraZeneca Live Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020) Table 107. AstraZeneca Product Table 108. AstraZeneca Recent Development Table 109. Global Live Vaccines Sales Forecast by Regions (2021-2026) (K Doses) Table 110. Global Live Vaccines Sales Market Share Forecast by Regions (2021-2026) Table 111. Global Live Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million) Table 112. Global Live Vaccines Revenue Market Share Forecast by Regions (2021-2026) Table 113. North America: Live Vaccines Sales Forecast by Country (2021-2026) (K Doses) Table 114. North America: Live Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 115. Europe: Live Vaccines Sales Forecast by Country (2021-2026) (K Doses) Table 116. Europe: Live Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 117. Asia Pacific: Live Vaccines Sales Forecast by Region (2021-2026) (K Doses) Table 118. Asia Pacific: Live Vaccines Revenue Forecast by Region (2021-2026) (US$ Million) Table 119. Latin America: Live Vaccines Sales Forecast by Country (2021-2026) (K Doses) Table 120. Latin America: Live Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 121. Middle East and Africa: Live Vaccines Sales Forecast by Country (2021-2026) (K Doses) Table 122. Middle East and Africa: Live Vaccines Revenue Forecast by Country (2021-2026) (US$ Million) Table 123. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 124. Key Challenges Table 125. Market Risks Table 126. Main Points Interviewed from Key Live Vaccines Players Table 127. Live Vaccines Customers List Table 128. Live Vaccines Distributors List Table 129. Research Programs/Design for This Report Table 130. Key Data Information from Secondary Sources Table 131. Key Data Information from Primary Sources List of Figures Figure 1. Live Vaccines Product Picture Figure 2. Global Live Vaccines Sales Market Share by Type in 2020 & 2026 Figure 3. Monovalent Live Vaccines Product Picture Figure 4. Multivalent Live Vaccines Product Picture Figure 5. Global Live Vaccines Sales Market Share by Application in 2020 & 2026 Figure 6. Adults Figure 7. Children Figure 8. Live Vaccines Report Years Considered Figure 9. Global Live Vaccines Market Size 2015-2026 (US$ Million) Figure 10. Global Live Vaccines Sales 2015-2026 (K Doses) Figure 11. Global Live Vaccines Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Global Live Vaccines Sales Market Share by Region (2015-2020) Figure 13. Global Live Vaccines Sales Market Share by Region in 2019 Figure 14. Global Live Vaccines Revenue Market Share by Region (2015-2020) Figure 15. Global Live Vaccines Revenue Market Share by Region in 2019 Figure 16. Global Live Vaccines Sales Share by Manufacturer in 2019 Figure 17. The Top 10 and 5 Players Market Share by Live Vaccines Revenue in 2019 Figure 18. Live Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Live Vaccines Sales Market Share by Type (2015-2020) Figure 20. Global Live Vaccines Sales Market Share by Type in 2019 Figure 21. Global Live Vaccines Revenue Market Share by Type (2015-2020) Figure 22. Global Live Vaccines Revenue Market Share by Type in 2019 Figure 23. Global Live Vaccines Market Share by Price Range (2015-2020) Figure 24. Global Live Vaccines Sales Market Share by Application (2015-2020) Figure 25. Global Live Vaccines Sales Market Share by Application in 2019 Figure 26. Global Live Vaccines Revenue Market Share by Application (2015-2020) Figure 27. Global Live Vaccines Revenue Market Share by Application in 2019 Figure 28. North America Live Vaccines Sales Growth Rate 2015-2020 (K Doses) Figure 29. North America Live Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 30. North America Live Vaccines Sales Market Share by Country in 2019 Figure 31. North America Live Vaccines Revenue Market Share by Country in 2019 Figure 32. U.S. Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 33. U.S. Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Canada Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 35. Canada Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. North America Live Vaccines Market Share by Type in 2019 Figure 37. North America Live Vaccines Market Share by Application in 2019 Figure 38. Europe Live Vaccines Sales Growth Rate 2015-2020 (K Doses) Figure 39. Europe Live Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 40. Europe Live Vaccines Sales Market Share by Country in 2019 Figure 41. Europe Live Vaccines Revenue Market Share by Country in 2019 Figure 42. Germany Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 43. Germany Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. France Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 45. France Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. U.K. Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 47. U.K. Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Italy Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 49. Italy Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Russia Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 51. Russia Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Europe Live Vaccines Market Share by Type in 2019 Figure 53. Europe Live Vaccines Market Share by Application in 2019 Figure 54. Asia Pacific Live Vaccines Sales Growth Rate 2015-2020 (K Doses) Figure 55. Asia Pacific Live Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 56. Asia Pacific Live Vaccines Sales Market Share by Region in 2019 Figure 57. Asia Pacific Live Vaccines Revenue Market Share by Region in 2019 Figure 58. China Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 59. China Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Japan Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 61. Japan Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. South Korea Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 63. South Korea Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. India Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 65. India Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Australia Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 67. Australia Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Taiwan Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 69. Taiwan Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Indonesia Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 71. Indonesia Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Thailand Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 73. Thailand Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Malaysia Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 75. Malaysia Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Philippines Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 77. Philippines Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Vietnam Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 79. Vietnam Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Asia Pacific Live Vaccines Market Share by Type in 2019 Figure 81. Asia Pacific Live Vaccines Market Share by Application in 2019 Figure 82. Latin America Live Vaccines Sales Growth Rate 2015-2020 (K Doses) Figure 83. Latin America Live Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 84. Latin America Live Vaccines Sales Market Share by Country in 2019 Figure 85. Latin America Live Vaccines Revenue Market Share by Country in 2019 Figure 86. Mexico Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 87. Mexico Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 88. Brazil Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 89. Brazil Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 90. Argentina Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 91. Argentina Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 92. Latin America Live Vaccines Market Share by Type in 2019 Figure 93. Latin America Live Vaccines Market Share by Application in 2019 Figure 94. Middle East and Africa Live Vaccines Sales Growth Rate 2015-2020 (K Doses) Figure 95. Middle East and Africa Live Vaccines Revenue Growth Rate 2015-2020 (US$ Million) Figure 96. Middle East and Africa Live Vaccines Sales Market Share by Country in 2019 Figure 97. Middle East and Africa Live Vaccines Revenue Market Share by Country in 2019 Figure 98. Turkey Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 99. Turkey Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 100. Saudi Arabia Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 101. Saudi Arabia Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 102. U.A.E Live Vaccines Sales Growth Rate (2015-2020) (K Doses) Figure 103. U.A.E Live Vaccines Revenue Growth Rate (2015-2020) (US$ Million) Figure 104. Middle East and Africa Live Vaccines Market Share by Type in 2019 Figure 105. Middle East and Africa Live Vaccines Market Share by Application in 2019 Figure 106. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 107. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 108. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 109. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 110. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 111. Emergent BioSolutions Total Revenue (US$ Million): 2019 Compared with 2018 Figure 112. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 113. North America Live Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses) Figure 114. North America Live Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 115. Europe Live Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses) Figure 116. Europe Live Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Asia Pacific Live Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses) Figure 118. Asia Pacific Live Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 119. Latin America Live Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses) Figure 120. Latin America Live Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 121. Middle East and Africa Live Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses) Figure 122. Middle East and Africa Live Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 123. Porter's Five Forces Analysis Figure 124. Channels of Distribution Figure 125. Distributors Profiles Figure 126. Bottom-up and Top-down Approaches for This Report Figure 127. Data Triangulation Figure 128. Key Executives Interviewed

Merck GlaxoSmithKline Pfizer Novartis Astellas Pharma Emergent BioSolutions AstraZeneca